MEM. HOSPITAL OF SHERIDAN CTY. — History
CCN 530006 | 3-year financial timeline | COVID resilience: 81/100
🛡️ Public data only — no PHI permitted on this instance.
$139M
Latest Revenue (FY2022)
+10.6%
Revenue CAGR (3yr)
-4.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $114M | $136M | $139M | +2.4% | +10.6% |
| Operating Expenses | $119M | $138M | $145M | +4.7% | +10.4% |
| Operating Margin | -4.3% | -1.8% | -4.0% | -121.7% | +0.0% |
| Net Income | $-5M | $-2M | $-6M | -127.1% | +0.0% |
| Licensed Beds | 71 | 71 | 88 | +23.9% | +11.3% |
| Total Patient Days | 9,651 | 11,683 | 10,962 | -6.2% | +6.6% |
| Medicare Day % | 56% | 52% | 50% | -3.0% | -5.2% |
| Medicaid Day % | 6% | 6% | 8% | +40.9% | +15.7% |
COVID Impact & Recovery
Resilience Score: 81/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +22.2% ($114M → $139M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.6%
This Hospital
+7.6%
State Avg
Latest Margin
-4.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $152M | -3.9% |
| FY2024 (proj) | $164M | -3.7% |
| FY2025 (proj) | $177M | -3.6% |